Chitosan Nanoparticles Inhibit Cholangiocarcinoma Tumor Growth and Glycolysis in Preclinical Study
Chitosan nanoparticles co-delivering albendazole and ursolic acid reduced tumor volume in mice and suppressed glycolytic enzyme activity in cholangiocarcinoma cells.







